{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:09:35Z","timestamp":1762456175310,"version":"build-2065373602"},"reference-count":9,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,12]],"date-time":"2021-07-12T00:00:00Z","timestamp":1626048000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EBioMedicine"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.ebiom.2021.103499","type":"journal-article","created":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T18:54:10Z","timestamp":1627498450000},"page":"103499","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Functional cure of chronic hepatitis B \u2013 predictable?"],"prefix":"10.1016","volume":"70","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6835-8031","authenticated-orcid":false,"given":"Wolfram","family":"Gerlich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2017","series-title":"Global Hepatitis Report 2017","key":"10.1016\/j.ebiom.2021.103499_bib0001"},{"key":"10.1016\/j.ebiom.2021.103499_bib0002","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.jhep.2017.05.008","article-title":"Hepatitis B cure: From discovery to regulatory approval","volume":"67","author":"Lok","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.ebiom.2021.103499_bib0003","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jhep.2019.11.003","article-title":"EASL-AASLD HBV Treatment Endpoints Conference Faculty. Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conference Faculty","volume":"72","author":"Cornberg","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.ebiom.2021.103499_bib0004","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"EASL 2017 Clinical Practice Guidelines on the management of hepatitis B 464 virus infection","volume":"67","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.ebiom.2021.103499_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103464","article-title":"Longitudinal characterization of phenotypic profile of T cells in chronic hepatitis B identifies immune markers associated with HBsAg loss","volume":"69","author":"Xiong","year":"2021","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ebiom.2021.103499_bib0006","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ebiom.2016.07.023","article-title":"Immunotherapy With the PreS-based Grass Pollen Allergy Vaccine BM32 Induces Antibody Responses Protecting Against Hepatitis B Infection","volume":"11","author":"Cornelius","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ebiom.2021.103499_bib0007","doi-asserted-by":"crossref","first-page":"e22334","DOI":"10.1002\/jcla.22334","article-title":"Evaluation of the highly sensitive chemiluminescent enzyme immunoassay \u201cLumipulse HBsAg-HQ\u201d for hepatitis B virus screening","volume":"32","author":"Deguchi","year":"2018","journal-title":"J Clin Lab Anal"},{"issue":"11","key":"10.1016\/j.ebiom.2021.103499_bib0008","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1136\/gutjnl-2017-313811","article-title":"Quantification of large and middle proteins of hepatitis B virus surface antigen (HBsAg) as a novel tool for the identification of inactive HBV carriers","volume":"67","author":"Pfefferkorn","year":"2018","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.ebiom.2021.103499_bib0009","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jhep.2020.08.039","article-title":"Composition of HBsAg is predictive of HBsAg loss during treatment in patients with HBeAg-positive chronic hepatitis B","volume":"74","author":"Pfefferkorn","year":"2021","journal-title":"J Hepatol"}],"container-title":["EBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396421002929?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396421002929?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:05:13Z","timestamp":1762455913000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396421002929"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":9,"alternative-id":["S2352396421002929"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2021.103499","relation":{},"ISSN":["2352-3964"],"issn-type":[{"type":"print","value":"2352-3964"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Functional cure of chronic hepatitis B \u2013 predictable?","name":"articletitle","label":"Article Title"},{"value":"EBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2021.103499","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2021.103464","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103499"}}